Caught on the wrong foot
24/06/20 -"Solvay’s €1.5bn impairment of the back of the current challenging business situation is the price the current management has to pay for the predecessor’s expensive decisions. The ..."
Pages
59
Language
English
Published on
24/06/20
You may also be interested by these reports :
07/11/25
Arkema’s Q3 2025 results were a mixed bag. Investor sentiment is likely supported by guidance matching consensus and management’s optimistic ...
06/11/25
Lanxess’s weak Q3 2025 results weighed heavily on investor sentiment, with shares down 12% as of writing. The company faced subdued end-market demand ...
06/11/25
The company faces challenges due to weak demand in its end markets. Management has made initial progress in restructuring, but improvement in these ...
03/11/25
Fuchs’ Q3 2025 results, although muted, came in line with street expectations. Sales were supported by strong performance in Asia and the Americas. ...